Trials / Completed
CompletedNCT03898960
Post Marketing Study to Evaluate the NIMBUS Device
Post Marketing Study of Patients to Evaluate NIMBUS Revascularization Effectiveness With Challenging Occlusions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Neuravi Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A post-market study evaluating the NIMBUS Device in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Detailed description
The objective of this study is to assess the efficacy of the NIMBUS Device. The study will also report on clot characteristics and clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NIMBUS Device | NIMBUS Geometric Clot Extractor |
Timeline
- Start date
- 2019-10-30
- Primary completion
- 2022-02-15
- Completion
- 2022-04-08
- First posted
- 2019-04-02
- Last updated
- 2025-04-25
- Results posted
- 2023-11-27
Locations
2 sites across 2 countries: Germany, Sweden
Source: ClinicalTrials.gov record NCT03898960. Inclusion in this directory is not an endorsement.